vs
Side-by-side financial comparison of Expeditors International (EXPD) and GE HealthCare (GEHC). Click either name above to swap in a different company.
GE HealthCare is the larger business by last-quarter revenue ($5.7B vs $2.9B, roughly 2.0× Expeditors International). GE HealthCare runs the higher net margin — 10.3% vs 7.0%, a 3.3% gap on every dollar of revenue. On growth, GE HealthCare posted the faster year-over-year revenue change (7.1% vs -3.3%). Over the past eight quarters, Expeditors International's revenue compounded faster (13.8% CAGR vs 10.7%).
Expeditors International of Washington, Inc. is an American Fortune 500 service-based logistics company with headquarters in Bellevue, Washington. Expeditors generates highly optimized and customized supply chain solutions for clients with unified technology systems integrated through a global network of over 340+ locations in 100+ countries on six continents.
GE Healthcare Technologies, Inc., stylized GE HealthCare, is an American health technology company based in Chicago, Illinois. It operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical Diagnostics, which manufactures...
EXPD vs GEHC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $2.9B | $5.7B |
| Net Profit | $200.7M | $588.0M |
| Gross Margin | — | 39.7% |
| Operating Margin | 8.8% | 14.5% |
| Net Margin | 7.0% | 10.3% |
| Revenue YoY | -3.3% | 7.1% |
| Net Profit YoY | -14.9% | -18.4% |
| EPS (diluted) | $1.50 | $1.28 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $2.9B | $5.7B | ||
| Q3 25 | $2.9B | $5.1B | ||
| Q2 25 | $2.7B | $5.0B | ||
| Q1 25 | $2.7B | $4.8B | ||
| Q4 24 | $3.0B | $5.3B | ||
| Q3 24 | $3.0B | $4.9B | ||
| Q2 24 | $2.4B | $4.8B | ||
| Q1 24 | $2.2B | $4.7B |
| Q4 25 | $200.7M | $588.0M | ||
| Q3 25 | $222.3M | $446.0M | ||
| Q2 25 | $183.6M | $486.0M | ||
| Q1 25 | $203.8M | $564.0M | ||
| Q4 24 | $235.9M | $721.0M | ||
| Q3 24 | $229.6M | $470.0M | ||
| Q2 24 | $175.5M | $428.0M | ||
| Q1 24 | $169.2M | $374.0M |
| Q4 25 | — | 39.7% | ||
| Q3 25 | — | 38.7% | ||
| Q2 25 | — | 39.6% | ||
| Q1 25 | — | 42.1% | ||
| Q4 24 | — | 42.8% | ||
| Q3 24 | — | 41.7% | ||
| Q2 24 | — | 41.4% | ||
| Q1 24 | — | 40.9% |
| Q4 25 | 8.8% | 14.5% | ||
| Q3 25 | 10.0% | 12.7% | ||
| Q2 25 | 9.3% | 13.1% | ||
| Q1 25 | 10.0% | 13.2% | ||
| Q4 24 | 10.2% | 15.1% | ||
| Q3 24 | 10.1% | 13.9% | ||
| Q2 24 | 9.2% | 12.6% | ||
| Q1 24 | 9.7% | 11.6% |
| Q4 25 | 7.0% | 10.3% | ||
| Q3 25 | 7.7% | 8.7% | ||
| Q2 25 | 6.9% | 9.7% | ||
| Q1 25 | 7.6% | 11.8% | ||
| Q4 24 | 8.0% | 13.6% | ||
| Q3 24 | 7.7% | 9.7% | ||
| Q2 24 | 7.2% | 8.8% | ||
| Q1 24 | 7.7% | 8.0% |
| Q4 25 | $1.50 | $1.28 | ||
| Q3 25 | $1.64 | $0.98 | ||
| Q2 25 | $1.34 | $1.06 | ||
| Q1 25 | $1.47 | $1.23 | ||
| Q4 24 | $1.68 | $1.58 | ||
| Q3 24 | $1.63 | $1.02 | ||
| Q2 24 | $1.24 | $0.93 | ||
| Q1 24 | $1.17 | $0.81 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.3B | $4.5B |
| Total DebtLower is stronger | — | $10.0B |
| Stockholders' EquityBook value | $2.4B | $10.4B |
| Total Assets | $4.9B | $36.9B |
| Debt / EquityLower = less leverage | — | 0.96× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.3B | $4.5B | ||
| Q3 25 | $1.2B | $4.0B | ||
| Q2 25 | $1.2B | $3.7B | ||
| Q1 25 | $1.3B | $2.5B | ||
| Q4 24 | $1.1B | $2.9B | ||
| Q3 24 | $1.3B | $3.5B | ||
| Q2 24 | $1.3B | $2.0B | ||
| Q1 24 | $1.4B | $2.6B |
| Q4 25 | — | $10.0B | ||
| Q3 25 | — | $10.3B | ||
| Q2 25 | — | $10.3B | ||
| Q1 25 | — | $8.8B | ||
| Q4 24 | — | $9.0B | ||
| Q3 24 | — | $10.3B | ||
| Q2 24 | — | $9.2B | ||
| Q1 24 | — | $9.3B |
| Q4 25 | $2.4B | $10.4B | ||
| Q3 25 | $2.3B | $10.0B | ||
| Q2 25 | $2.2B | $9.7B | ||
| Q1 25 | $2.3B | $9.2B | ||
| Q4 24 | $2.2B | $8.4B | ||
| Q3 24 | $2.4B | $8.3B | ||
| Q2 24 | $2.2B | $7.8B | ||
| Q1 24 | $2.2B | $7.4B |
| Q4 25 | $4.9B | $36.9B | ||
| Q3 25 | $4.8B | $36.1B | ||
| Q2 25 | $4.8B | $35.5B | ||
| Q1 25 | $4.8B | $33.6B | ||
| Q4 24 | $4.8B | $33.1B | ||
| Q3 24 | $5.2B | $33.9B | ||
| Q2 24 | $4.8B | $31.9B | ||
| Q1 24 | $4.5B | $32.2B |
| Q4 25 | — | 0.96× | ||
| Q3 25 | — | 1.03× | ||
| Q2 25 | — | 1.06× | ||
| Q1 25 | — | 0.95× | ||
| Q4 24 | — | 1.06× | ||
| Q3 24 | — | 1.24× | ||
| Q2 24 | — | 1.18× | ||
| Q1 24 | — | 1.25× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $283.3M | — |
| Free Cash FlowOCF − Capex | $270.3M | — |
| FCF MarginFCF / Revenue | 9.5% | — |
| Capex IntensityCapex / Revenue | 0.5% | 2.4% |
| Cash ConversionOCF / Net Profit | 1.41× | — |
| TTM Free Cash FlowTrailing 4 quarters | $953.4M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $283.3M | — | ||
| Q3 25 | $201.4M | — | ||
| Q2 25 | $179.2M | $94.0M | ||
| Q1 25 | $342.6M | $250.0M | ||
| Q4 24 | $249.7M | — | ||
| Q3 24 | $90.0M | — | ||
| Q2 24 | $126.8M | $-119.0M | ||
| Q1 24 | $256.9M | $419.0M |
| Q4 25 | $270.3M | — | ||
| Q3 25 | $190.3M | — | ||
| Q2 25 | $163.3M | $8.0M | ||
| Q1 25 | $329.5M | $98.0M | ||
| Q4 24 | $239.7M | — | ||
| Q3 24 | $77.7M | — | ||
| Q2 24 | $118.8M | $-183.0M | ||
| Q1 24 | $246.7M | $274.0M |
| Q4 25 | 9.5% | — | ||
| Q3 25 | 6.6% | — | ||
| Q2 25 | 6.2% | 0.2% | ||
| Q1 25 | 12.4% | 2.1% | ||
| Q4 24 | 8.1% | — | ||
| Q3 24 | 2.6% | — | ||
| Q2 24 | 4.9% | -3.8% | ||
| Q1 24 | 11.2% | 5.9% |
| Q4 25 | 0.5% | 2.4% | ||
| Q3 25 | 0.4% | 2.1% | ||
| Q2 25 | 0.6% | 1.7% | ||
| Q1 25 | 0.5% | 3.2% | ||
| Q4 24 | 0.3% | 1.9% | ||
| Q3 24 | 0.4% | 1.9% | ||
| Q2 24 | 0.3% | 1.3% | ||
| Q1 24 | 0.5% | 3.1% |
| Q4 25 | 1.41× | — | ||
| Q3 25 | 0.91× | — | ||
| Q2 25 | 0.98× | 0.19× | ||
| Q1 25 | 1.68× | 0.44× | ||
| Q4 24 | 1.06× | — | ||
| Q3 24 | 0.39× | — | ||
| Q2 24 | 0.72× | -0.28× | ||
| Q1 24 | 1.52× | 1.12× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
EXPD
| Customs Brokerage And Other Services | $1.1B | 40% |
| Airfreight Services | $1.1B | 39% |
| Ocean Freight And Ocean Services | $611.4M | 21% |
GEHC
| Imaging Segment | $2.6B | 45% |
| PCS Segment | $824.0M | 14% |
| P Dx Segment | $790.0M | 14% |
| Specialized Ultrasound Subsegment | $735.0M | 13% |
| Monitoring Solutions Subsegment | $578.0M | 10% |
| Life Support Solutions Subsegment | $247.0M | 4% |
